XML 47 R36.htm IDEA: XBRL DOCUMENT
v3.22.1

Earnings Per Common Share (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2022
Earnings Per Share [Abstract] |
Schedule of Computation of Basic and Diluted Earnings per Share | The following table illustrates the computation of basic and diluted earnings per share (in thousands, except per share amounts):
| Three Months Ended March 31, |  |
| 2022 |  | 2021 |  |  |  |
Numerator |  |  |  |  |  |  |
Income (loss) from continuing operations | $ | 75,026 |  |  | $ | (120,585) |  |  |  |  |
Noncontrolling interests' share in continuing operations | (3,730) |  |  | (3,306) |  |  |  |  |
Income (loss) from continuing operations attributable to Healthpeak Properties, Inc. | 71,296 |  |  | (123,891) |  |  |  |  |
Less: Participating securities' share in continuing operations | (1,976) |  |  | (2,451) |  |  |  |  |
Income (loss) from continuing operations applicable to common shares | 69,320 |  |  | (126,342) |  |  |  |  |
Income (loss) from discontinued operations | 317 |  |  | 270,008 |  |  |  |  |
Noncontrolling interests' share in discontinued operations | — |  |  | (329) |  |  |  |  |
Net income (loss) applicable to common shares | $ | 69,637 |  |  | $ | 143,337 |  |  |  |  |
Denominator |  |  |  |  |  |  |
Basic weighted average shares outstanding | 539,352 |  |  | 538,679 |  |  |  |  |
Dilutive potential common shares - equity awards(1) | 234 |  |  | — |  |  |  |  |
Diluted weighted average common shares | 539,586 |  |  | 538,679 |  |  |  |  |
Basic earnings (loss) per common share |  |  |  |  |  |  |
Continuing operations | $ | 0.13 |  |  | $ | (0.23) |  |  |  |  |
Discontinued operations | 0.00 |  |  | 0.50 |  |  |  |  |
Net income (loss) applicable to common shares | $ | 0.13 |  |  | $ | 0.27 |  |  |  |  |
Diluted earnings (loss) per common share |  |  |  |  |  |  |
Continuing operations | $ | 0.13 |  |  | $ | (0.23) |  |  |  |  |
Discontinued operations | 0.00 |  |  | 0.50 |  |  |  |  |
Net income (loss) applicable to common shares | $ | 0.13 |  |  | $ | 0.27 |  |  |  |  |
_______________________________________ (1)For all periods presented, represents the dilutive impact of 1 million outstanding equity awards (restricted stock units and stock options). For the three months ended March 31, 2022, the 9.1 million shares under forward sales agreements that have not been settled as of March 31, 2022 were anti-dilutive. For the three months ended March 31, 2021, forward sales agreements had no dilutive impact as no shares remained outstanding under ATM forward contracts during the period.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration